Halucenex Life Sciences Inc.
1 clinical trials · Sponsor
◉ Watch Halucenex Life Sciences Inc.
| Record | Firm | Date |
|---|---|---|
| Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder (NCT05243329) | Halucenex Life Sciences Inc. | 2022-10-03 |
Track Halucenex Life Sciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.